'''Avitriptan''' ([[International Nonproprietary Name|INN]]) (code name '''BMS-180,048''') is an [[antimigraine drug]] of the [[triptan]] family which was never marketed.<ref name="pmid9050026">{{cite journal|vauthors=Saxena PR, De Vries P, Wang W |title=Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential |journal=Naunyn-Schmiedeberg's Archives of Pharmacology |volume=355 |issue=2 |pages=295â€“302 |date=February 1997 |pmid=9050026 |doi=10.1007/pl00004946 |url=http://link.springer.de/link/service/journals/00210/bibs/7355002/73550295.htm |display-authors=etal |deadurl=yes |archiveurl=https://web.archive.org/web/19991023052058/http://link.springer.de/link/service/journals/00210/bibs/7355002/73550295.htm |archivedate=1999-10-23 |df= }}</ref> It acts as a [[5-HT1B receptor|5-HT<sub>1B</sub>]] and [[5-HT1D receptor|5-HT<sub>1D</sub> receptor]] [[agonist]].<ref name="pmid9050026"/>
